Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allogenic Ex-vivo Expanded Bone Marrow Derived Mesenchymal Stem Cells in Knee Osteoarthritis
2023-503974-19-00Phase 3Withdrawn
- Sponsor
- University Hospital Odense
- Start
- Jul 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised trial of allogeneic bone marrow-derived mesenchymal stromal cells in osteoarthritis (OA), sponsored by University Hospital Odense. Planned start Jul 2025; status: withdrawn.
02
Drugs
allogeneic bone marrow-derived mesenchymal stromal cells
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2023-503974-19-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-503974-19-00.